Back to results
US 2008/0287448 A1Published application
Diacyl indazole derivatives as lipase and phospholipase inhibitors
AssigneeSanofi-Aventis
InventorsGerhard Zoller, Stefan Petry, Gunter Muller, Hubert Heuer, Norbert Tennagels
Life of this patent
Estimating the term…
Abstract
The invention relates to diacyl indazole derivatives of general formulae (I) or (II) and to the pharmaceutically acceptable salts thereof: Wherein X, R1 and R2 are as defined herein. The invention also relates to the use of these compounds as pharmaceutical products.
Claims25
A compound of the formulae I or II:
- wherein
- X is identically or differently ═C(—R)— or ═N—, where not more than two X are ═N—;
- R is identically or differently hydrogen, halogen, (C1-C6)-alkyl, (C1-C3)-alkyloxy-(C1-C3)-alkylene, (C1-C3)-haloalkyl, hydroxy, (C1-C6)-alkyl-mercapto, amino, (C1-C6)-alkylamino, di-(C2-C12)-alkylamino, mono-(C1-C6)-alkylaminocarbonyl, di-(C2-C8)-alkylaminocarbonyl, COOR3, cyano, (C1-C6)-alkylsulfonyl, (C1-C6)-alkylsulfinyl, aminosulfonyl, nitro, pentafluorosulfanyl, phenyl, heterocycle, phenoxy, O-heterocycle, CO—NR6R7, O—CO—NR6R7, O—CO—(C1-C6)-alkylene-CO—O—(C1-C6)-alkyl, O—CO—(C1-C6)-alkylene-CO—OH, O—CO—(C1-C6)-alkylene-CO—NR6R7 or unsubstituted or mono- or poly-F-substituted (C1-C6)-alkyloxy;
- R1 is identically or differently (C5-C16)-alkyl, (C3-C12)-cycloalkyl, Y-aryl, Y-heterocycle or bicycle, where cycloalkyl, aryl, heterocycle or bicycle are optionally substituted one or more times by halogen, (C1-C6)-alkyl, (C1-C3)-alkyloxy, hydroxy, (C1-C6)-alkylmercapto, amino, (C1-C6)-alkylamino, di-(C2-C12)-alkylamino, mono-(C1-C6)-alkylaminocarbonyl, di-(C2-C8)-alkylaminocarbonyl, (C1-C6)-alkyloxycarbonyl, (C1-C6)-alkylcarbonyl, cyano, trifluoromethyl, trifluoromethyloxy, (C1-C6)-alkylsulfonyl, aminosulfonyl, and nitro;
- Y is (C1-C3)-alkyl, which is optionally substituted one or more times by halogen, (C1-C3)-alkyl, hydroxy or trifluoromethyl;
- R2 is hydrogen;
- or
- R1 and R2 together with the nitrogen atom carrying them form a monocyclic, saturated or partly unsaturated 4- to 7-membered ring system or a bicyclic saturated or partly unsaturated 8- to 14-membered ring system whose individual members of the ring systems are optionally replaced by one to three atoms or atomic groups from the series —CHR4-, —CR4R5-, —(C═R4)-, —NR4-, —C(═O)—, —O—, —S—, —SO—, —SO2—, with the proviso that two units from the series —O—, —S—, —SO—, —SO2— are not adjacent to each other;
- R3 is hydrogen, (C1-C6)-alkyl or benzyl;
- R4, R5 are identically or differently (C1-C6)-alkyl, halogen, trifluoromethyl, phenyl, heterocycle, COOR3 or (C3-C12)-cycloalkyl;
- and
- R6, R7 are identically or differently hydrogen, (C1-C6)-alkyl, phenyl, benzyl or (C3-C12)-cycloalkyl;
- or
- a tautomer thereof or a physiologically tolerated salt thereof,
- with the proviso that not more than one R is phenyl or heterocycle.
12 more elements
Dependencies are inferred from the claim text.